Aetna’s new report, The Business of health 2020 – Tackling polarised perceptions of corporate health and wellness, looks at how technology can positively impact employee mental ill health and lifestyle-related health conditions in an increasingly blurred work-life balance in the workplace. The report was published in January 2020. With wellbeing now being broader in scope than previously understood, it has come to include physical and emotional health, financial security, social
Aetna report shows differing perceptions among employers and employees globally There is a major gulf between how employers view the health and wellness support offered and employees’ views of the support they receive. This could have a significant impact on productivity, according to research from Aetna International published in November 2019. The first of two Business of Health 2020 reports, Tackling polarised perceptions of corporate health and wellness, investigates
Aetna in May 2019 announced the launch of DNA testing as an optional part of its wellness plans for its European members. The DNA test examines aspects of health and lifestyle, in particular nutrigenomics (the relationship between genes, nutrition and health), fitness, sleep and stress. The goal of the DNA testing is to help members take control of their health and support them to make positive lifestyle changes. Employers
Give an Hour, a US-based, not-for-profit mental health services organization in June 2019 partnered with high profile companies including Facebook, Aetna and IBM to promote global awareness around mental health. The week-long global public education initiative called A Week to Change Direction ran from June 9 to June 15, 2019 with projects registered in 18 countries including Australia, Canada, China, Colombia, Czech Republic, Germany, India, Kenya, South Africa, Turkey,
CVS Health and Aetna in June 2018 announced their post-merger leadership team. Aetna President Karen Lynch will stay on as executive vice president of CVS and president of the Aetna business unit. Richard di Benedetto will continue in his current role as president of Aetna International. Shawn Guertin, Aetna’s CFO and chief enterprise risk officer, will become executive vice president and CFO of CVS. Fran Soistman, executive vice president
Global health care benefits provider Aetna International in March 2018 announced that it has acquired Canadian Insurance in Hong Kong, and is now licensed to offer health insurance in Hong Kong. The license allows Aetna International to market its products and services solely under the Aetna brand. Aetna’s history in Asia started in 2007 as a specialist health insurer in Hong Kong, via its acquisition of Goodhealth. Hong Kong
Three months after the December 2017 announcement that CVS Health had purchased Aetna, their respective shareholders on March 13, 2018 voted to approve the proposed $69 billion merger of the companies at special meetings. As discussed in an earlier post, the acquisition sets the stage for a new type of company that will include a health insurer, a retail pharmacy, and a pharmacy benefits manager that negotiates prescription drug
Aviva, the UK’s largest general insurer and a leading life and pensions provider, in January 2018 announced its intention to withdraw from the international private medical insurance (iPMI) market, following a strategic review which found that iPMI “is not central” to the company’s focus on growing its health business in the UK. As of 1 May 2018, existing iPMI customers will be able to continue coverage by accepting a
Aetna in November 2017 sold its group life and disability insurance and absence management business to The Hartford for $1.45bn. Life and disability was the only non-health insurance related part of the business remaining after Aetna cut its property casualty insurance business in the mid-1990s. It only brought in about $2bn in premiums in 2016, while Aetna recorded $63.1bn in total revenue, and healthcare premium revenues reached $54.1bn. The
The announcement that CVS Health has purchased Aetna, referred to in our earlier news item, was made on Sunday, 4 December 2017, laying to rest months of rumor and speculation. The acquisition sets the stage for a new type of company that will include a health insurer, a retail pharmacy, and a pharmacy benefits manager that negotiates prescription drug prices with drug-makers. The announcement comes at a time when
Aetna International has announced the launch of Access US, a product aimed at helping any non-US headquartered company that currently has, or is hiring, American citizens based in the USA. The Access US Plans are an ideal fit for companies with geographically dispersed employees located in the US. They are an ACA-compliant (Obamacare-compliant) medical product designed for organizations with 50 or more total employees worldwide and allow US companies
CVS Health, an American drug store chain that also operates walk-in health clinics and a pharmacy benefit business, in October 2017 was reported to be in talks to purchase Aetna Insurance in a deal that could be worth more than $60 billion based on Aetna’s current market value. This would make the purchase one of the largest in the history of the health industry. CVS, with the addition of
Aetna International, a subsidiary of Aetna, in May 2017 announced the redesign of Health Hub, its health care benefits secure member portal, after an extensive review of the service. The redesign allows users to search for information about a subscriber’s health, and allows subscribers to have secure access to their insurance and healthcare needs from any location. Members can view their plan details, access claim records, and search for
Aetna International in February 2017 announced the appointment of Andy O’Cain as New Business Sales Director, in charge of the development and growth of the self insured corporate sector (ASO) in the large group market. Based in the U.K., Andy joins Aetna International from Cigna Insurance Services where he was Head of Sales and Business Development, having previously been Head of Travel Development. Prior to Cigna, Andy was Head
The U.S. District Court for the District of Columbia in January 2017 found that Aetna’s proposed merger with Humana fell afoul of antitrust laws and ordered it to stop. According to Judge John Bates, the efficiencies generated by the merger will not be sufficient to mitigate the anti-competitive effects for consumers, specifically in respect of individual Medicare Advantage plans and of individual commercial insurance on the public exchanges in
U.S. health insurance providers Aetna and Humana in December 2016 announced they had come to an agreement to extend the deadline for their proposed merger from December 31, 2016 to February 15, 2017, as U.S. federal courts are poised to decide whether to allow the merger to proceed. The decision is expected by mid-January. The deal was first announced in August 2015.
Shareholders of Aetna and Humana in October 2015 voted separately and approved overwhelmingly the health insurers’ proposed $37 billion merger. Aetna shareholders approved the issuance of up to 127 million common shares to Humana stockholders, who agreed to the terms of the July 2015 merger agreement with Aetna as finalized in July. The deal is expected to close in the second half of 2016 after the approval of state
Rick Jelinek joined Aetna in October 2015 as executive vice president in charge of the Aetna-Humana integration, as well as of Aetna’s enterprise strategy. In July 2015, Aetna announced plans to acquire Humana, which would approximately double its size. Jelinek reports to Aetna’s Chairman and CEO Mark T. Bertolini and joins Aetna’s Executive Committee. Prior to Aetna, Jelinek was an operating partner with Advent International, a private equity firm.
Aetna will acquire Humana for cash and stock valued at $37 billion. The acquisition will push Aetna’s Medicare Advantage membership to 4.4 million and make it possible for the two companies to share knowledge and innovations in order to create better healthcare products, the company said. The deal is subject to regulatory and other approvals; it is expected to be completed in late 2015.